PK/PD Study of YZJ-1139

NCT06685341 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.